Familial Hypercholesterolemia
📧 Sign up to get email alerts when something new happens for Familial Hypercholesterolemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-08-03Clinical Trial Update: To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED) [Phase 3]
A Phase 3 trial assessed the lipid-lowering effects of combining ezetimibe/simvastatin with extended-release niacin in patients with Type II…
-
FDA approval · 2009-07-21FDA Approved: ZETIA — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Zetia (ezetimibe) submitted by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2009-07-20Clinical Trial Update: PLUTO: Pediatric Lipid-redUction Trial of rOsuvastatin [Phase 3]
Phase 3 PLUTO trial evaluated rosuvastatin for lipid reduction in children with familial hypercholesterolemia; the results were posted in Ju…
-
CLINICAL_TRIALS research · 2009-06-18Clinical Trial Update: Effect of Rapeseed Oil and Sunflower Oil [NA]
This document provides a clinical trial update on the effects of rapeseed oil and sunflower oil in individuals with familial hypercholestero…
-
CLINICAL_TRIALS research · 2009-06-18Clinical Trial Update: Soy Food Intervention Trial [NA]
This is a clinical trial update about a soy food intervention for Familial Hypercholesterolemia; the trial status is unknown.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-03-27FDA Approved: LIPITOR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Lipitor (atorvastatin calcium) submitted by Viatris Specialty LLC.
-
FDA approval · 2008-11-06FDA Approved: CRESTOR — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for CRESTOR (rosuvastatin) from AstraZeneca Pharmaceuticals LP. The approval updates the labeling to…
-
FDA approval · 2008-06-13FDA Approved: VYTORIN — Supplemental Application (Organon LLC)
FDA approved a supplemental application for VYTORIN (ezetimibe and simvastatin) from Organon LLC.
-
CLINICAL_TRIALS trial_result · 2008-06-03Clinical Trial Update: Efficacy and Safety Study of JTT-705 in Combination With Pravastatin 40 mg in Patients With Type II Hyperlipidemia [Phase 2]
Phase 2 trial evaluating the combination of JTT-705 and pravastatin 40 mg for Type II hyperlipidemia has completed, reporting on efficacy an…
-
CLINICAL_TRIALS research · 2008-03-21Clinical Trial Update: Evaluation of Chylomicrons Metabolism in Sub-Clinical Atherosclerosis in Patients Whit Heterozigous Familial Hypercholesterolemia (FH) Treated With Statin Plus Ezetimibe [NA]
A clinical trial update examining chylomicron metabolism in sub-clinical atherosclerosis among patients with heterozygous familial hyperchol…
-
FDA approval · 2008-01-15FDA Approved: PRAVASTATIN SODIUM — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for pravastatin sodium by Aurobindo Pharma Limited, confirming a generic pravastatin product. The drug…
-
FDA approval · 2008-01-08FDA Approved: PRAVASTATIN SODIUM — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' generic pravastatin sodium tablets under Original Application, enabling a generic statin to enter the ma…
-
FDA approval · 2007-12-28FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (CIPLA USA INC.)
FDA approved a supplemental application for pravastatin sodium submitted by Cipla USA Inc., signaling an additional regulatory approval for …
-
FDA approval · 2007-11-26FDA Approved: ZOCOR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for ZOCOR (simvastatin) from Organon LLC.
-
CLINICAL_TRIALS trial_result · 2007-11-07Clinical Trial Update: Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Patients With Genetic High Cholesterol Disorder [Phase 3]
This clinical trial update reports the completion of a Phase 3 study evaluating torcetrapib in combination with atorvastatin for familial hy…
-
CLINICAL_TRIALS trial_result · 2007-10-30Clinical Trial Update: Study To Evaluate The Safety And Efficacy Of Torcetrapib/Atorvastatin In Subjects With Familial Hypercholerolemia [Phase 3]
Pfizer conducted a Phase 3 trial evaluating the safety and efficacy of a torcetrapib/atorvastatin combination in subjects with familial hype…
-
FDA approval · 2007-10-05FDA Approved: LOVASTATIN — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Lovastatin submitted by Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2007-09-26FDA Approved: LIPITOR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Lipitor (atorvastatin calcium) submitted by Viatris Specialty LLC.
-
FDA approval · 2007-05-11FDA Approved: PRAVASTATIN SODIUM — Original Application (CIPLA USA INC.)
FDA approved a generic pravastatin sodium product (Pravastatin Sodium) from Cipla USA Inc. through an Original Application (ANDA). This mark…
-
FDA approval · 2007-05-11FDA Approved: SIMVASTATIN — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' original ANDA for simvastatin (generic). The approval adds a generic option for lowering cholesterol in …
-
FDA approval · 2006-05-23FDA Approved: ZETIA — Supplemental Application (Organon LLC)
The FDA has approved a supplemental application for Zetia (ezetimibe) submitted by Organon LLC.